Rosetta Genomics, Ltd. (ROSG)
-NasdaqCM 3.80 
0.04(1.04%) Jun 19, 3:59PM EDT
| Prev Close: | 3.84 |
|---|
| Open: | 3.85 |
|---|
| Bid: | 1.50 x 1000 |
|---|
| Ask: | 4.47 x 1600 |
|---|
| 1y Target Est: | 10.00 |
|---|
| Beta: | -4.54 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 3.70 - 3.89 |
|---|
| 52wk Range: | 3.09 - 13.76 |
|---|
| Volume: | 220,230 |
|---|
| Avg Vol (3m): | 384,152 |
|---|
| Market Cap: | 34.57M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.35 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test™PR Newswire(Thu, Jun 13)
- 4 Healthcare Stock Stories As a Weekend Investment Prescriptionat Wall St. Cheat Sheet(Fri, Jun 7)
- Wal-Mart Okays Share Buyback, AT&T and Sprint Included in NSA Sweep, and 2 More Hot Stocksat Wall St. Cheat Sheet(Fri, Jun 7)
- Rosetta Genomics executes credentialing agreement with Three Riversat theflyonthewall.com(Fri, Jun 7)
- Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider NetworkPR Newswire(Fri, Jun 7)
- 4 Healthcare Stock Stories Creating a Thursday Buzzat Wall St. Cheat Sheet(Thu, Jun 6)
- 5 Stocks Under $10 Set to Soarat TheStreet(Thu, Jun 6)
- Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test ManuscriptPR Newswire(Thu, Jun 6)
- 3 Health Care Stocks Under $10 to Watchat TheStreet(Tue, Jun 4)
- Rosetta Genomics expands in U.S.theflyonthewall.com(Tue, Jun 4)
- Rosetta Genomics to Increase the Number of U.S. Sales TerritoriesPR Newswire(Tue, Jun 4)
- Rosetta Genomics Announces Presence at ASCO 2013PR Newswire(Tue, May 28)
- Rosetta Genomics to Present at the Jefferies 2013 Healthcare ConferencePR Newswire(Wed, May 22)
- BRIEF-Rosetta Genomics up 11.8 percent in premarket tradeat Reuters(Mon, May 20)
- Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2PR Newswire(Mon, May 20)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 173.79 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Sep-11)
: | N/A |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Rosetta Genomics Ltd. develops and commercializes a range of microRNA-based diagnostic tools. MicroRNAs are a group of genes that are produced using instructions encoded in DNA.
View More